Logo image of VENU

VENU HOLDING CORP (VENU) Stock Fundamental Analysis

NYSEARCA:VENU - NYSE Arca - US92333E1047 - Common Stock - Currency: USD

11.32  -0.61 (-5.11%)

Fundamental Rating

3

Taking everything into account, VENU scores 3 out of 10 in our fundamental rating. VENU was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. VENU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VENU has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VENU has reported negative net income.
In the past year VENU has reported a negative cash flow from operations.
VENU Yearly Net Income VS EBIT VS OCF VS FCFVENU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

VENU has a worse Return On Assets (-15.41%) than 87.97% of its industry peers.
The Return On Equity of VENU (-41.86%) is worse than 63.16% of its industry peers.
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROIC N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VENU Yearly ROA, ROE, ROICVENU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

VENU's Gross Margin of 46.51% is in line compared to the rest of the industry. VENU outperforms 47.37% of its industry peers.
The Profit Margin and Operating Margin are not available for VENU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VENU Yearly Profit, Operating, Gross MarginsVENU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

VENU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VENU has been increased compared to 1 year ago.
The debt/assets ratio for VENU is higher compared to a year ago.
VENU Yearly Shares OutstandingVENU Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
VENU Yearly Total Debt VS Total AssetsVENU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that VENU is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VENU (1.13) is worse than 61.65% of its industry peers.
VENU has a Debt/Equity ratio of 0.69. This is a neutral value indicating VENU is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, VENU is in the better half of the industry, outperforming 66.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC8.63%
VENU Yearly LT Debt VS Equity VS FCFVENU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 2.72 indicates that VENU has no problem at all paying its short term obligations.
The Current ratio of VENU (2.72) is better than 93.23% of its industry peers.
VENU has a Quick Ratio of 2.70. This indicates that VENU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.70, VENU belongs to the top of the industry, outperforming 93.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.7
VENU Yearly Current Assets VS Current LiabilitesVENU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for VENU have decreased strongly by -186.29% in the last year.
VENU shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.57%.
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

Based on estimates for the next years, VENU will show a very strong growth in Earnings Per Share. The EPS will grow by 114.33% on average per year.
VENU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 225.43% yearly.
EPS Next Y170.31%
EPS Next 2Y114.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year102.82%
Revenue Next 2Y225.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VENU Yearly Revenue VS EstimatesVENU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 50M 100M 150M
VENU Yearly EPS VS EstimatesVENU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VENU. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.69, the valuation of VENU can be described as very cheap.
Based on the Price/Forward Earnings ratio, VENU is valued cheaper than 94.74% of the companies in the same industry.
VENU's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE N/A
Fwd PE 6.69
VENU Price Earnings VS Forward Price EarningsVENU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VENU Per share dataVENU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

VENU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VENU's earnings are expected to grow with 114.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VENU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENU HOLDING CORP

NYSEARCA:VENU (6/27/2025, 8:04:00 PM)

11.32

-0.61 (-5.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)N/A N/A
Inst Owners3.14%
Inst Owner Change153.35%
Ins Owners27.17%
Ins Owner Change-0.5%
Market Cap424.73M
Analysts82.5
Price Target14.45 (27.65%)
Short Float %0.18%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)-5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-28.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.69
P/S 24.42
P/FCF N/A
P/OCF N/A
P/B 5.42
P/tB 5.43
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)1.69
Fwd EY14.96%
FCF(TTM)-2.35
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.46
BVpS2.09
TBVpS2.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.51%
FCFM N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1934.1%
Cap/Sales 492.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.7
Altman-Z 1.13
F-Score2
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)1444.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)249.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
EPS Next Y170.31%
EPS Next 2Y114.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next Year102.82%
Revenue Next 2Y225.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.06%
OCF growth 3YN/A
OCF growth 5YN/A